Brickell Biotech, Inc.·4

Sep 21, 4:19 PM ET

McAvoy David R. 4

4 · Brickell Biotech, Inc. · Filed Sep 21, 2020

Insider Transaction Report

Form 4
Period: 2020-09-18
McAvoy David R.
General Counsel
Transactions
  • Purchase

    Common Stock

    2020-09-18$0.83/sh+16,526$13,71375,883 total
  • Purchase

    Common Stock

    2020-09-18$0.84/sh+6,000$5,0396,000 total(indirect: By Spouse)
Footnotes (1)
  • [F1]Represents the purchase of 16,526 shares in multiple transactions, ranging in price from $0.8224 to $0.8429 per share, resulting in a weighted average purchase price of $0.8298. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES